Update on the usage and safety of epinephrine auto-injectors, 2017

DSpace/Manakin Repository

Update on the usage and safety of epinephrine auto-injectors, 2017

Citable link to this page


Title: Update on the usage and safety of epinephrine auto-injectors, 2017
Author: Posner, Larry S; Camargo, Carlos A

Note: Order does not necessarily reflect citation order of authors.

Citation: Posner, Larry S., and Carlos A Camargo. 2017. “Update on the usage and safety of epinephrine auto-injectors, 2017.” Drug, Healthcare and Patient Safety 9 (1): 9-18. doi:10.2147/DHPS.S121733. http://dx.doi.org/10.2147/DHPS.S121733.
Full Text & Related Files:
Abstract: Anaphylaxis is a serious, potentially fatal allergic reaction. Guidelines recommend prompt intramuscular injections of epinephrine as the first-line therapy for anaphylaxis. Delayed epinephrine treatment may cause undesirable clinical outcomes, including death. In the community, epinephrine auto-injectors (EAIs) are commonly used to treat anaphylaxis. This literature review examines several recent concerns regarding the safety of EAIs that may prevent the timely administration of epinephrine. Reports of cardiovascular complications are linked with epinephrine administration, although recent studies suggest that these events are much more commonly associated with intravenous epinephrine rather than with EAIs. Recent studies have also highlighted accidental injections of EAIs in patients’ or caregivers’ fingers and lacerations associated with the use of EAI in children. However, the data suggest that both accidental injections and lacerations are rare and require limited medical intervention. In addition, patients may receive conflicting information on the safety and efficacy of using expired EAIs. Overall, it is believed that the benefits of using EAIs far outweigh the potential risks of not administering an EAI. Although legitimate safety concerns are associated with EAIs, adverse events are rare. Continued training of medical providers, caregivers, and patients may be beneficial to address these concerns and reduce EAI-associated injuries while ensuring that patients receive necessary medical care.
Published Version: doi:10.2147/DHPS.S121733
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367766/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:32072219
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search